Literature DB >> 33111477

ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE.

Adrian Liew1, Sunita Bavanandan2, Narayan Prasad3, Muh Geot Wong4,5, Jer Ming Chang6, Somchai Eiam-Ong7, Chuan-Ming Hao8, Chiao Yuen Lim9, Soo Kun Lim10, Kook-Hwan Oh11, Hirokazu Okada12, Paweena Susantitaphong7, Aida Lydia13, Huong Thi Bich Tran14, Russell Villanueva15, See Cheng Yeo16, Sydney C W Tang17.   

Abstract

Entities:  

Year:  2020        PMID： 33111477     DOI： 10.1111/nep.13785

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN： 1320-5358            Impact factor:   2.506


× No keyword cloud information.
  5 in total

1.  The Predictive Value of Visceral Adiposity Index and Lipid Accumulation Index for Microalbuminuria in Newly Diagnosed Type 2 Diabetes Patients.

Authors:  Licui Qi; Ning Kang; Yong Li; Hang Zhao; Shuchun Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-11       Impact factor: 3.168

2.  Development of a Risk Model for Predicting Microalbuminuria in the Chinese Population Using Machine Learning Algorithms.

Authors:  Wei Lin; Songchang Shi; Huibin Huang; Nengying Wang; Junping Wen; Gang Chen
Journal:  Front Med (Lausanne)       Date:  2022-02-07

3.  Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy.

Authors:  Shunlai Shang; Shaoyuan Cui; Wenjuan Wang; Chao Wang; Ping Li; Wenge Li; Qinggang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-30       Impact factor: 6.055

4.  miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1.

Authors:  Shuyue Sheng; Meina Zou; Yanlin Yang; Meiping Guan; Shijing Ren; Xiangyu Wang; Ling Wang; Yaoming Xue
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-10-04       Impact factor: 2.416

5.  Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation.

Authors:  Hui Feng; Xiaoyun Zhu; Yang Tang; Shouqiang Fu; Bingtan Kong; Ximing Liu
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.